|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei
WQ, Qiao YL and Inoue M: Comparative epidemiology of gastric cancer
between Japan and China. World J Gastroenterol. 17:4421–4428. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma MR and Schilsky RL: GI cancers in
2010: New standards and a predictive biomarker for adjuvant
therapy. Nat Rev Clin Oncol. 8:70–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smyth EC and Cunningham D: Gastric cancer
in 2012: Defining treatment standards and novel insights into
disease biology. Nat Rev Clin Oncol. 10:73–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nobili S, Bruno L, Landini I, Napoli C,
Bechi P, Tonelli F, Rubio CA, Mini E and Nesi G: Genomic and
genetic alterations influence the progression of gastric cancer.
World J Gastroenterol. 17:290–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jang BG and Kim WH: Molecular pathology of
gastric carcinoma. Pathobiology. 78:302–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yasui W, Sentani K, Sakamoto N, Anami K,
Naito Y and Oue N: Molecular pathology of gastric cancer: Research
and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan IB, Ng I, Tai WM and Tan P:
Understanding the genetic basis of gastric cancer: Recent advances.
Expert Rev Gastroenterol Hepatol. 6:335–341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
A-Hassan E, Heinz WF, Antonik MD, D'Costa
NP, Nageswaran S, Schoenenberger CA and Hoh JH: Relative
microelastic mapping of living cells by atomic force microscopy.
Biophys J. 74:1564–1578. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pickart CM and Fushman D: Polyubiquitin
chains: Polymeric protein signals. Curr Opin Chem Biol. 8:610–616.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okamoto Y, Ozaki T, Miyazaki K, Aoyama M,
Miyazaki M and Nakagawara A: UbcH10 is the cancer-related E2
ubiquitin-conjugating enzyme. Cancer Res. 63:4167–4173.
2003.PubMed/NCBI
|
|
13
|
Rape M and Kirschner MW: Autonomous
regulation of the anaphase-promoting complex couples mitosis to
S-phase entry. Nature. 432:588–595. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rape M, Reddy SK and Kirschner MW: The
processivity of multiubiquitination by the APC determines the order
of substrate degradation. Cell. 124:89–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Ree JH, Jeganathan KB, Malureanu L and
van Deursen JM: Overexpression of the E2 ubiquitin-conjugating
enzyme UbcH10 causes chromosome missegregation and tumor formation.
J Cell Biol. 188:83–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perrotta I, Bruno L, Maltese L, Russo E,
Donato A and Donato G: Immunohistochemical analysis of the
ubiquitin-conjugating enzyme UbcH10 in lung cancer: A useful tool
for diagnosis and therapy. J Histochem Cytochem. 60:359–365. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pallante P, Berlingieri MT, Troncone G,
Kruhoffer M, Orntoft TF, Viglietto G, Caleo A, Migliaccio I,
Decaussin-Petrucci M, Santoro M, et al: UbcH10 overexpression may
represent a marker of anaplastic thyroid carcinomas. Br J Cancer.
93:464–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kefeli M, Yildiz L, Celik H, Tosun M and
Karagoz F: UbcH10 expression in benign, hyperplastic, and malignant
endometrial curetted materials: A tissue microarray study. Int J
Surg Pathol. 20:360–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Z, Jiang X, Zeng C, Zheng S, Luo B,
Zeng Y, Ding R, Jiang H, He Q, Guo J, et al: High expression of
ubiquitin-conjugating enzyme 2C (UBE2C) correlates with
nasopharyngeal carcinoma progression. BMC Cancer. 13:1922013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ieta K, Ojima E, Tanaka F, Nakamura Y,
Haraguchi N, Mimori K, Inoue H, Kuwano H and Mori M: Identification
of overexpressed genes in hepatocellular carcinoma, with special
reference to ubiquitin-conjugating enzyme E2C gene expression. Int
J Cancer. 121:33–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berlingieri MT, Pallante P, Sboner A,
Barbareschi M, Bianco M, Ferraro A, Mansueto G, Borbone E,
Guerriero E, Troncone G, et al: UbcH10 is overexpressed in
malignant breast carcinomas. Eur J Cancer. 43:2729–2735. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fujita T, Ikeda H, Taira N, Hatoh S, Naito
M and Doihara H: Overexpression of UbcH10 alternates the cell cycle
profile and accelerate the tumor proliferation in colon cancer. BMC
Cancer. 9:872009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Chen Y, Hu C, Jing H, Cao Y and
Liu X: Association of clinicopathological features with UbcH10
expression in colorectal cancer. J Cancer Res Clin Oncol.
136:419–426. 2010. View Article : Google Scholar
|
|
24
|
Jiang L, Huang CG, Lu YC, Luo C, Hu GH,
Liu HM, Chen JX and Han HX: Expression of ubiquitin-conjugating
enzyme E2C/UbcH10 in astrocytic tumors. Brain Res. 1201:161–166.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen SM, Jiang CY, Wu JY, Liu B, Chen YJ,
Hu CJ and Liu XX: RNA interference-mediated silencing of UBCH10
gene inhibits colorectal cancer cell growth in vitro and in vivo.
Clin Exp Pharmacol Physiol. 37:525–529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Bao Y, Luo C, Hu G, Huang C, Ding
X, Sun K and Lu Y: Knockdown of ubiquitin-conjugating enzyme
E2C/UbcH10 expression by RNA interference inhibits glioma cell
proliferation and enhances cell apoptosis in vitro. J Cancer Res
Clin Oncol. 136:211–217. 2010. View Article : Google Scholar
|
|
27
|
Lodhia KA, Hadley AM, Haluska P and Scott
CL: Prioritizing therapeutic targets using patient-derived
xenograft models. Biochim Biophys Acta. 1855:223–234.
2015.PubMed/NCBI
|
|
28
|
Choi SY, Lin D, Gout PW, Collins CC, Xu Y
and Wang Y: Lessons from patient-derived xenografts for better in
vitro modeling of human cancer. Adv Drug Deliv Rev. 79–80:222–237.
2014. View Article : Google Scholar
|
|
29
|
John T, Kohler D, Pintilie M, Yanagawa N,
Pham NA, Li M, Panchal D, Hui F, Meng F, Shepherd FA, et al: The
ability to form primary tumor xenografts is predictive of increased
risk of disease recurrence in early-stage non-small cell lung
cancer. Clin Cancer Res. 17:134–141. 2011. View Article : Google Scholar
|
|
30
|
Sicklick JK, Leonard SY, Babicky ML, Tang
CM, Mose ES, French RP, Jaquish DV, Hoh CK, Peterson M, Schwab R,
et al: Generation of orthotopic patient-derived xenografts from
gastrointestinal stromal tumor. J Transl Med. 12:412014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin Y, Hwang WC and Basavappa R:
Structural and functional analysis of the human mitotic-specific
ubiquitin-conjugating enzyme, UbcH10. J Biol Chem. 277:21913–21921.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takahashi Y, Ishii Y, Nishida Y, Ikarashi
M, Nagata T, Nakamura T, Yamamori S and Asai S: Detection of
aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in
advanced colon cancer with liver metastases by DNA microarray and
two-color FISH. Cancer Genet Cytogenet. 168:30–35. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee JJ, Au AY, Foukakis T, Barbaro M, Kiss
N, Clifton-Bligh R, Staaf J, Borg A, Delbridge L, Robinson BG, et
al: Array-CGH identifies cyclin D1 and UBCH10 amplicons in
anaplastic thyroid carcinoma. Endocr Relat Cancer. 15:801–815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G,
Wan X, Hoang A, Efstathiou E, Sircar K, Navone NM, et al: Modeling
a lethal prostate cancer variant with small-cell carcinoma
features. Clin Cancer Res. 18:666–677. 2012. View Article : Google Scholar
|
|
35
|
Donato G, Iofrida G, Lavano A, Volpentesta
G, Signorelli F, Pallante PL, Berlingieri MT, Pierantoni MG,
Palmieri D, Conforti F, et al: Analysis of UbcH10 expression
represents a useful tool for the diagnosis and therapy of
astrocytic tumors. Clin Neuropathol. 27:219–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin J, Raoof DA, Wang Z, Lin MY, Thomas
DG, Greenson JK, Giordano TJ, Orringer MB, Chang AC, Beer DG, et
al: Expression and effect of inhibition of the
ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.
Neoplasia. 8:1062–1071. 2006. View Article : Google Scholar
|
|
37
|
Troncone G, Guerriero E, Pallante P,
Berlingieri MT, Ferraro A, Del Vecchio L, Gorrese M, Mariotti E,
Iaccarino A, Palmieri EA, et al: UbcH10 expression in human
lymphomas. Histopathology. 54:731–740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vasiljevic A, Champier J,
Figarella-Branger D, Wierinckx A, Jouvet A and Fèvre-Montange M:
Molecular characterization of central neurocytomas: Potential
markers for tumor typing and progression. Neuropathology.
33:149–161. 2013. View Article : Google Scholar
|
